Ben Stevens is an Editor at various publications, including Outsourced Pharma and Skiddle. He specializes in themes such as cannabis and psychedelics, with a focus on cannabidiol (CBD), cannabis business, and cannabis regulation, as well as competitive sports. Ben's work has been featured in a wide range of outlets, including Yahoo News UK, Bioprocess Online, and Edutopia.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Ben’s coverage mainly focuses on event coverage within the realm of sports, with particular emphasis on basketball and American football. Given this focus, he is likely to be most responsive to pitches that provide detailed previews or analyses of upcoming games or events in these sports.
For example, providing insights into key players' performances, injury updates, or emerging trends could be valuable for Ben's articles. Additionally, offering unique perspectives on coaching changes and their potential impact on teams might also garner his interest.
As there is no specific geographic focus mentioned for Ben's coverage area, pitches related to any NBA or NFL team matchup would be relevant regardless of location.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Ben Stevens
PGP Farmer , the French biotech developing what it describes as the country's first EU-GMP medical cannabis production site, has launched a proof-of-concept phenotyping programme in the Netherlands, testing 30 cannabis genotypes from its own genetic library to determine which varieties will be cultivated at its Dordogne facility.
By: Ben Stevens
Cannabis Europa London returns on 26-27 May 2026, bringing together operators, investors, clinicians, and policymakers from across the global cannabis industry for two days of main-stage debate, exhibition, and networking. This article is part of a series published by
By: Ben Stevens
Jersey's medical cannabis industry turned a profit for the first time in 2025, posting revenues of £12m, almost £50m in cumulative investment, and exports of nearly seven tonnes.
By: Ben Stevens
By As Europe's medical cannabis market matures, a new category of operator is beginning to emerge.
By: Ben Stevens
Voices of Cannabis Europa: Philip Schetter, Joshua Cuby and Gabriel Newman, Cantourage
By: Ben Stevens
By Former heavyweight boxing contender Derek Chisora has revealed he is using prescribed medical cannabis to manage chronic pain following more than 20 years in professional boxing.
By: Ben Stevens
By Tilray Medical , a global leader in medical cannabis research, cultivation, production, products and distribution and a division of Tilray
By: Matthias Meyer, Ben Stevens, Lawrence Purkiss
Cannabis Europa London is back at The Barbican Centre for two days of conversations with global cannabis leaders, policymakers, industry analysts and patient representatives, and, as ever, the sun has shown up.
By Cannabis Europa 2026 From Plant to Patient: Why Genetics Must Lead Medical Cannabis Outcomes
By: Ben Stevens
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to VER-01, the flagship full-spectrum cannabis drug from Munich-based Vertanical, putting it in prime position to become […]
